Stocks and Investing
Stocks and Investing
Fri, October 27, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, October 26, 2023
[ 12:00 AM ] - United States, WOPRAI
Ami Fadia Reiterated (BIIB) at Strong Buy and Held Target at $305 on, Oct 26th, 2023
Ami Fadia of Needham, Reiterated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $305 on, Oct 26th, 2023.
Ami has made no other calls on BIIB in the last 4 months.
There are 13 other peers that have a rating on BIIB. Out of the 13 peers that are also analyzing BIIB, 2 agree with Ami's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $275 on, Tuesday, August 8th, 2023
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $294 on, Tuesday, August 8th, 2023
These are the ratings of the 11 analyists that currently disagree with Ami
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $361 on, Wednesday, October 11th, 2023
- Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $360 on, Wednesday, September 6th, 2023
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $357 on, Tuesday, August 29th, 2023
- Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $335 on, Monday, August 14th, 2023
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $340 on, Tuesday, August 8th, 2023
- Evan Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $336 on, Tuesday, August 8th, 2023
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $343 on, Monday, August 7th, 2023
- Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $290 on, Monday, August 7th, 2023
- George Farmer of "Scotiabank" Initiated at Buy and Held Target at $327 on, Thursday, July 27th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Wednesday, July 26th, 2023
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $320 on, Tuesday, July 25th, 2023
Contributing Sources